Showing results (401-410 of 633) with videos related to
Sort By:
Pageof 64
European Journal of Pharmacology|May 26, 1998
Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosisS Kaku, K Umemura, A Mizuno, et al.Japanese Heart Journal|May 28, 1998
Comparison of class II and class III activity of dl-sotalol in healthy volunteersM Kimura, K Umemura, Y Ikeda, et al.Therapeutic Drug Monitoring|January 1, 1989
Prediction of individual dosage requirements for lignocaine: a validation study for Bayesian forecasting in Japanese patientsT Uematsu, H Hirayama, S Nagashima, et al.Journal of Biochemical Toxicology|January 1, 1990
Niacin attenuates bleomycin-induced lung fibrosis in the hamsterQ J Wang, S N Giri, D M Hyde, et al.Biological & Pharmaceutical Bulletin|November 5, 1999
Construction of the single-chain Fv from 196-14 antibody toward ovarian cancer-associated antigen CA125Y Hashimoto, K Tanigawa, M Nakashima, et al.Plant & Cell Physiology|July 1, 1995
Plant homologues of components of MAPK (mitogen-activated protein kinase) signal pathways in yeast and animal cellsR Nishihama, H Banno, W Shibata, et al.Journal of Cardiovascular Pharmacology|April 1, 1994
Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction modelK Kondoh, H Hashimoto, H Nishiyama, et al.Journal of Clinical Pharmacology|November 1, 1993
Aldose reductase inhibitory and uricosuric activities of FK366 in healthy volunteersM Kanamaru, T Uematsu, S Nagashima, et al.Journal of Gastroenterology|February 1, 1996
Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphomaS Shikuwa, M Ito, M Nakashima, et al.European Journal of Immunology|January 1, 1990
Selective elimination of double-positive immature thymocytes by a thymic epithelial cell lineM Nakashima, K Mori, K Maeda, et al.Pageof 64